PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.\', \'German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.\', \'Department of Internal Medicine II, University Hospital, LMU Munich, Munich, Germany.\', \'Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, WHO Collaborating Centre for Occupational Health, LMU University Hospital, Munich, Germany.\', \'Occupational Medical Centre, LMU University Hospital, Munich, Germany.\', \'Department of Clinical microbiology & hospital hygiene, University Hospital, LMU Munich, Munich, Germany.\', \'Max von Pettenkofer Institute, Virology, Faculty of Medicine, LMU Munich, 80336, Munich, Germany.\', \'Department of Radiation Oncology, Heinrich Heine University of Düsseldorf, Düsseldorf, Germany.\', \'Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany. Maximilian.niyazi@med.uni-muenchen.de.\', \'German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. Maximilian.niyazi@med.uni-muenchen.de.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13014-020-01609-0
?:doi
?:hasPublicationType
?:journal
  • Radiation oncology (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32646505
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all